Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New hypnotic agents: clinical studies in general practice.

D Wheatley

    Pharmacology, Biochemistry, and Behavior
    |April 1, 1988
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial.

    ESMO open·2025
    Same author

    Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2025
    Same author

    Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Counterpoint: Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?

    Clinical oncology (Royal College of Radiologists (Great Britain))·2021
    Same author

    Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2020
    Same author

    Breast radiotherapy: less is more?

    Clinical oncology (Royal College of Radiologists (Great Britain))·2012
    Same journal

    Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Spontaneous oxycodone withdrawal alters behavior and oligodendrocyte-related gene expression in mice.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Improvement in depressive symptoms in people undergoing cognitive behavioral therapy who supplemented with probiotics: An open-label, pilot study.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Long-term follow-up of children with autism spectrum disorder and severe treatment-resistant behavioral symptoms treated with purified cannabidiol.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease.

    Pharmacology, biochemistry, and behavior·2026
    See all related articles

    Choosing the right hypnotic medication is key for treating sleep problems. Non-benzodiazepine hypnotics like zopiclone and zolpidem offer effective alternatives with fewer side effects and dependence risks compared to traditional options.

    Area of Science:

    • Pharmacology
    • Sleep Medicine
    • Clinical Trials

    Background:

    • Appropriate hypnotic selection for sleep disorders depends on factors like duration of action.
    • Benzodiazepines, while effective, carry risks of daytime after-effects and dependence.
    • Non-benzodiazepine hypnotics present potential alternatives for sleep disorder management.

    Purpose of the Study:

    • To compare the efficacy and safety of non-benzodiazepine hypnotics against established treatments and placebo.
    • To evaluate zopiclone against temazepam in a cross-over trial.
    • To assess the effects of zolpidem at different dosages versus placebo.

    Main Methods:

    • A cross-over trial involving 36 patients compared zopiclone to temazepam.
    • A parallel group study with 88 patients compared zolpidem (10 mg and 20 mg) to placebo.

    Related Experiment Videos

  • Both studies utilized double-blind comparative trial designs.

    • Main Results:

    • Zopiclone demonstrated similar hypnotic effects to temazepam.
    • Both 10 mg and 20 mg doses of zolpidem significantly improved sleep parameters compared to placebo.
    • Zolpidem exhibited negligible side effects and no rebound insomnia.

    Conclusions:

    • Non-benzodiazepine hypnotics, zopiclone and zolpidem, are effective alternatives for managing sleep disorders.
    • Zolpidem shows significant hypnotic efficacy with a favorable safety profile.
    • These findings support the use of zolpidem and zopiclone in clinical practice for insomnia treatment.